Repositorio Dspace

Cancer patient outcomes correlate with activating-KIR/ligand repertoires associated with distinct NK cell transcriptomic profiles

Mostrar el registro sencillo del ítem

dc.contributor.author Ruiz-Lorente, Inmaculada
dc.contributor.author Vallejo-Pulido, Andres
dc.contributor.author López-Abad, Alicia
dc.contributor.author López-Cubillana, Pedro
dc.contributor.author Barozi, Victor
dc.contributor.author Khakoo, Salim-I.
dc.contributor.author Minguela-Puras, Alfredo
dc.contributor.author Gimeno-Arias, Lourdes
dc.date.accessioned 2026-11-18T11:23:21Z
dc.date.available 2026-11-18T11:23:21Z
dc.date.issued 2026-12-31
dc.identifier.citation Ruiz-Lorente I, Vallejo-Pulido A, López-Abad A, López Cubillana P, Barozi V, Khakoo SI, et al. Cancer patient outcomes correlate with activating-KIR
dc.identifier.issn 2162-402X
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/29302
dc.description.abstract BACKGROUND: Rates of cancer cure increase; however, recurrence and refractoriness remain clinical challenges that require alternative therapeutic strategies. Natural killer (NK) cells could play a decisive role if their antitumor reactivity can be enhanced. The interaction between killer-cell immunoglobulin-like receptors (KIRs) and their human leukocyte antigen class-I (HLA-I) ligands significantly influences NK-cell education and may impact clinical outcomes in cancer patients. In this study, we evaluated the impact of KIR/HLA-I interactions on the transcriptomic profile of circulating NK-cells and their association with patient outcome. METHODS: KIR and HLA-I genotyping, together with KIR expression analysis in circulating NK cells, were performed in patients with solid and hematologic malignancies (n = 1,153). In addition, single-cell transcriptomic analyses (scRNA-seq) of circulating NK and T lymphocytes were carried out in selected donors with KIR/HLA-I genotypes associated with short and long survival. RESULTS: Activating KIRs (aKIRs), more than inhibitory KIRs, were associated with cancer patient outcomes. The accumulation of aKIR-HLA interactions was related to shorter overall survival, whereas KIR2DS1/C2 interaction, in the absence of other aKIR interactions, was associated with longer survival. Three major NK-cell transcriptional profiles were identified: mature cytotoxic, immature/regulatory, and adaptive cytotoxic. The adaptive-like transcriptional profile was associated with longer survival. CONCLUSIONS: In conclusion, aKIR/HLA-I interactions were associated with cancer patient outcomes. In particular, KIR2DS1/C2 interaction in the absence of other activating signals was associated with adaptive NK-cell transcriptomic profiles and improved survival. Understanding the mechanisms underlying effective NK-cell-mediated tumor immunity may provide new opportunities for patients with refractory tumors.
dc.language.iso eng
dc.publisher TAYLOR & FRANCIS INC
dc.rights Atribución/Reconocimiento-NoComercial 4.0 Internacional
dc.rights.uri https://creativecommons.org/licenses/by-nc/4.0/deed.es *
dc.subject.mesh Humans
dc.subject.mesh Killer Cells, Natural/immunology/metabolism
dc.subject.mesh Receptors, KIR/genetics/metabolism
dc.subject.mesh Transcriptome
dc.subject.mesh Female
dc.subject.mesh Neoplasms/genetics/immunology/mortality
dc.subject.mesh Male
dc.subject.mesh Ligands
dc.subject.mesh Gene Expression Profiling
dc.subject.mesh Middle Aged
dc.subject.mesh Genotype
dc.subject.mesh Histocompatibility Antigens Class I/genetics/metabolism
dc.subject.mesh Prognosis
dc.subject.mesh Adult
dc.subject.mesh Aged
dc.title Cancer patient outcomes correlate with activating-KIR/ligand repertoires associated with distinct NK cell transcriptomic profiles
dc.type info:eu-repo/semantics/article
dc.identifier.pmid 42980150
dc.relation.publisherversion https://www.tandfonline.com/doi/full/10.1080/2162402X.2026.2756722
dc.type.version info:eu-repo/semantics/publishedVersion
dc.identifier.doi 10.1080/2162402X.2026.2756722
dc.journal.title ONCOIMMUNOLOGY


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución/Reconocimiento-NoComercial 4.0 Internacional Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución/Reconocimiento-NoComercial 4.0 Internacional

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta